Online Cognitive Behavioral Therapy Targeting Cardiac Anxiety
MI-CBT
1 other identifier
interventional
96
1 country
1
Brief Summary
The purpose of the present study is to evaluate an internet-delivered exposure-based cognitive behavioral therapy (CBT) protocol tailored for patients following myocardial infaction (MI) to increase Quality of Life (Qol) and physical activity by reducing cardiac anxiety.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 7, 2022
CompletedFirst Posted
Study publicly available on registry
October 14, 2022
CompletedStudy Start
First participant enrolled
October 17, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 14, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 14, 2025
CompletedAugust 27, 2024
August 1, 2024
2.4 years
October 7, 2022
August 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Seattle Angina Questionnaire
A measure of coronary artery disease on five scales: physical limitation scale, anginal stability scale, anginal frequency scale, treatment satisfaction scale, and the disease. perception scale with a score ranging from 0 to 100. A higher score indicating a better quality of life.
From baseline to 5 months
Secondary Outcomes (66)
Seattle Angina Questionnaire
From baseline to 8 weeks
Seattle Angina Questionnaire
Change over 8 measurement points measured from baseline and weekly for 8 weeks during treatment
Seattle Angina Questionnaire
From baseline to 1 year and 2 months
Seattle Angina Questionnaire
From baseline to 2 years and 2 months
Seattle Angina Questionnaire
From baseline to 5 years and 2 months
- +61 more secondary outcomes
Other Outcomes (23)
Number of Participants With Abnormal Laboratory Values
From Baseline to 8 weeks
Number of Participants With Abnormal Laboratory Values
From Baseline to 5 months
Algometry (Somedic AB, Hörby, Sweden)
From Baseline to 8 weeks
- +20 more other outcomes
Study Arms (2)
Online CBT targeting cardiac anxiety
EXPERIMENTALCBT for MI primarily targets two processes of MI-related disability: fear of cardiac-related symptoms avoidance behavior and physical inactivity. The CBT is therapist-guided and lasts for 8 weeks.
Waitlist control
NO INTERVENTIONParticipants randomised to waitlist can have no other concurrent psychological treatment but are free to use any medical treatment as usual. Participants on the waitlist also complete pre- and post-treatment, the follow-up measurement as well as weekly instruments (with exception of the treatment process measures Credibility scale and WAI). After the 3-month follow-up assessments, participants will receive internet-CBT for MI over 8 weeks
Interventions
* Education Common reactions following MI and general lifestyle advice on e.g., physical activity. The role of cardiac anxiety and avoidance behavior on quality of life and physical health. Brief training in self-observation. * Goal setting Identifying life areas impaired by MI-related disability or symptom fear. Set health behavioral goals i.e., increased physical activity and gradually take steps towards them. * Exposure therapy Exposure to physical sensations (e.g., palpitations due to physical activity) to reduce fear of these symptoms. Gradual exposure to avoided situations, activities and increase in physical activity. * Relapse prevention Prevention of relapse into avoidance behaviors by identifying risk situations and conduct a plan forward on maintaining a healthy physically and active lifestyle.
Eligibility Criteria
You may qualify if:
- Myocardial infarction ≥ 6 months before assessment (type 1 STEMI/NSTEMI)
- Age 18-80 years;
- Clinically significant cardiac anxiety that leads to severe distress and/or interferes with daily life
- On adequate medical treatment(21); (E) Able to read and write in Swedish.
You may not qualify if:
- heart failure with severe systolic dysfunction (ejection fraction ≤ 35%)
- Significant valvular disease
- Planned coronary artery bypass surgery or percutaneous interventions
- Any medical restriction to physical exercise
- Severe medical illness
- Grade 3 hypertension (i.e., blood pressure ≥ 180 systolic and/or 110 diastolic)
- Severe psychiatric disorder or risk of suicide
- Alcohol dependency
- Ongoing psychological treatment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Karolinska Institutetlead
- Swedish Heart Lung Foundationcollaborator
- The Swedish Research Councilcollaborator
- Sahlgrenska University Hospitalcollaborator
Study Sites (1)
Karolinska University Hospital
Stockholm, 11635, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, PhD
Study Record Dates
First Submitted
October 7, 2022
First Posted
October 14, 2022
Study Start
October 17, 2022
Primary Completion
March 14, 2025
Study Completion
March 14, 2025
Last Updated
August 27, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share